OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
In silicoscreening combined with bioactivity evaluation to identify AMI-1 as a novel anticancer compound by targeting AXL
Linxiao Wang, Yufeng An, Xiongpiao Wei, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 15, pp. 7686-7698
Closed Access | Times Cited: 6
Linxiao Wang, Yufeng An, Xiongpiao Wei, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 15, pp. 7686-7698
Closed Access | Times Cited: 6
Showing 6 citing articles:
EIF4A3 targeted therapeutic intervention in glioblastoma multiforme using phytochemicals from Indian medicinal plants – an integration of phytotherapy into precision onco-medicine
Sohini Kulavi, Debajit Dhar, Izaz Monir Kamal, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-21
Closed Access | Times Cited: 5
Sohini Kulavi, Debajit Dhar, Izaz Monir Kamal, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-21
Closed Access | Times Cited: 5
T6496 targeting EGFR mediated by T790M or C797S mutant: machine learning, virtual screening and bioactivity evaluation study
Linxiao Wang, Dang Fan, Wei Ruan, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-12
Closed Access | Times Cited: 2
Linxiao Wang, Dang Fan, Wei Ruan, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-12
Closed Access | Times Cited: 2
Fused in silico and bioactivity evaluation method for drug discovery: T001-10027877 was identified as an antiproliferative agent that targets EGFRT790M/C797S/L858R and EGFRT790M/L858R
Linxiao Wang, Xiaoling Huang, Shidi Xu, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Linxiao Wang, Xiaoling Huang, Shidi Xu, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
In silico method and bioactivity evaluation to discover novel antimicrobial agents targeting FtsZ protein: Machine learning, virtual screening and antibacterial mechanism study
Linxiao Wang, Zhouling Xie, Wei Ruan, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 398, Iss. 1, pp. 601-616
Closed Access
Linxiao Wang, Zhouling Xie, Wei Ruan, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 398, Iss. 1, pp. 601-616
Closed Access
ROC-guided virtual screening, molecular dynamics simulation, and bioactivity validation assessment Z195914464 as a 3CL Mpro inhibitor
Xiongpiao Wei, Min Li, Yuanbiao Tu, et al.
Biophysical Chemistry (2024) Vol. 317, pp. 107357-107357
Closed Access
Xiongpiao Wei, Min Li, Yuanbiao Tu, et al.
Biophysical Chemistry (2024) Vol. 317, pp. 107357-107357
Closed Access
Revealing 5-(3,5-difluorobenzyl)-1H-indazole as the active pharmacophore of ALK/ROS1 dual inhibitors through theoretical calculations and biological activity evaluations
Xiaoling Huang, Shidi Xu, Yufeng An, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108014-108014
Closed Access
Xiaoling Huang, Shidi Xu, Yufeng An, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108014-108014
Closed Access
